These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 17470993)

  • 21. Current concepts and management strategies in chronic kidney disease-mineral and bone disorder.
    Chauhan V; Kelepouris E; Chauhan N; Vaid M
    South Med J; 2012 Sep; 105(9):479-85. PubMed ID: 22948328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Kidney and bone update : the 5-year history and future of CKD-MBD. Bone biopsy and histomorphometrical analysis].
    Tsukamoto Y
    Clin Calcium; 2012 Jul; 22(7):1019-24. PubMed ID: 22750934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue.
    Toussaint ND; Elder GJ; Kerr PG
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):221-33. PubMed ID: 18987295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mineral metabolism and bone abnormalities in children with chronic renal failure.
    Sanchez CP
    Rev Endocr Metab Disord; 2008 Jun; 9(2):131-7. PubMed ID: 18175221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [CKD-MBD (chronic kidney disease-mineral and bone disorder). CKD-MBD: chronic kidney disease-mineral and bone disorder].
    Mizobuchi M; Aoshima Y; Akizawa T
    Clin Calcium; 2010 Jul; 20(7):995-1003. PubMed ID: 20585177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy.
    Sabbagh Y; Graciolli FG; O'Brien S; Tang W; dos Reis LM; Ryan S; Phillips L; Boulanger J; Song W; Bracken C; Liu S; Ledbetter S; Dechow P; Canziani ME; Carvalho AB; Jorgetti V; Moyses RM; Schiavi SC
    J Bone Miner Res; 2012 Aug; 27(8):1757-72. PubMed ID: 22492547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mineral metabolism and cardiovascular disease in CKD.
    Fujii H; Joki N
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):53-63. PubMed ID: 28062938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Chronic Kidney Disease Mineral and Bone Disorder on Jaw and Alveolar Bone Metabolism: A Narrative Review.
    Kanjevac T; Bijelic B; Brajkovic D; Vasovic M; Stolic R
    Oral Health Prev Dent; 2018; 16(1):79-85. PubMed ID: 29459907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mineral bone disorders in chronic kidney disease.
    Hou YC; Lu CL; Lu KC
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():88-94. PubMed ID: 30298663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The expanding concept of CKD-MBD].
    Komaba H
    Clin Calcium; 2016 Sep; 26(9):1253-60. PubMed ID: 27561339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone Disease in Chronic Kidney Disease and Kidney Transplant.
    Bellorin-Font E; Rojas E; Martin KJ
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Parathyroid and bone. Management of parathyroid function and evaluation of bone metabolism in hemodialysis patients].
    Goto S; Fukagawa M
    Clin Calcium; 2007 Dec; 17(12):1830-4. PubMed ID: 18057657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current therapeutic approach of chronic kidney disease-mineral and bone disorder.
    Zaimi M; Grapsa E
    Ther Apher Dial; 2024 Oct; 28(5):671-689. PubMed ID: 38898685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBD.
    Brandenburg VM; D'Haese P; Deck A; Mekahli D; Meijers B; Neven E; Evenepoel P
    Pediatr Nephrol; 2016 Feb; 31(2):195-206. PubMed ID: 25735207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Morphological analysis of bone dynamics and metabolic bone disease. Bone Histomorphometry in CKD-MBD (chronic kidney disease mineral bone disorder)].
    Yamamoto N
    Clin Calcium; 2011 Apr; 21(4):589-92. PubMed ID: 21447927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Kidney and bone update : the 5-year history and future of CKD-MBD. About the guideline of the Japanese Society for Dialysis Therapy].
    Yokoyama K
    Clin Calcium; 2012 Jul; 22(7):979-86. PubMed ID: 22750929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults.
    Bellorin-Font E; Ambrosoni P; Carlini RG; Carvalho AB; Correa-Rotter R; Cueto-Manzano A; Jara A; Jorgetti V; Negri AL; Olaizola I; Salusky I; Slatopolsky E; Weisinger JR; ;
    Nefrologia; 2013; 33 Suppl 1():1-28. PubMed ID: 23629678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consequences of chronic kidney disease--mineral and bone disorder: a progressive disease.
    Smith KR; Smelt SC
    Nephrol Nurs J; 2009; 36(1):49-55. PubMed ID: 19271624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mineral and bone disorders in patients on dialysis: physiology and clinical consequences.
    McCarley PB; Arjomand M
    Nephrol Nurs J; 2008; 35(1):59-64. PubMed ID: 18372764
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.